January 30, 2017 / 10:57 PM / 10 months ago

BRIEF-Aeterna Zentaris completes Zoptrex(tm) pivotal Phase 3 clinical trial in advanced endometrial cancer

Jan 30 (Reuters) - Aeterna Zentaris Inc

* Aeterna Zentaris announces completion of Zoptrex(TM) pivotal Phase 3 clinical trial in advanced endometrial cancer; expects to report top-line results in April 2017

* Aeterna Zentaris Inc - Currently expects to lock clinical database and to report top-line results in April 2017 for Phase 3 zoptec with zoptrex

* Aeterna Zentaris Inc - Occurrence of 384th death in pivotal phase 3 zoptec study with zoptrex Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below